R&DWelcome to CUMIQ, where innovation and quality collide to provide professional insights, high-caliber solutions, and a flawless experience that is customized just for you.
Regulatory toxicity is one of the numerous fields of expertise that our pre-clinical division (PCF) develops in order to present an investigational new drug (IND). several certifications in microbiology and pharmacology.
In order to increase environmental safety and security, our biotech research focuses on replacing the current chemical manufacturing methods of diverse intermediates with fermentation and enzymatic-based conversions.
We have rapidly grown into a fully integrated Indian pharmaceutical company by working with all six groups of APIs, CRAMS-labeled generics, monitored generics, and NCEs.
The pharmaceutical research division has distinct departments for local, emergent, and regulated markets in addition to sections dedicated to antibiotics and non-antibiotics. Additionally, a proposal for cutting-edge veterinary formulations is being developed.
Read Less